Delivery Order SPE2DB24D2109-SPE2DB26FHVTV
Award Date 10/23/25
Potential Completion Date 10/24/25
Potential Value $3.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,037.03 for 100 capsules of Lisdexamfetamine 50 mg, a prescription medication used to treat attention deficit hyperactivity disorder. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 2, 2025, with performance conducted at the company's corporate office in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $1,045.17 to AmerisourceBergen Drug Corp for 90 capsules of Lisdexamfetamine 30 mg, a controlled pharmaceutical used to treat attention deficit hyperactivity disorder. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure, with an ultimate completion date of November 6, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 100 capsules of Lisdexamfetamine 20 mg, a Schedule II controlled substance commonly prescribed for attention deficit hyperactivity disorder. This firm fixed price delivery order, valued at $4,136.15, was competitively awarded without set-aside designation and is scheduled for completion by September 26, 2025. The award leverages AmerisourceBergen's established position as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100 capsules of Lisdexamfetamine 60 mg, a controlled-release ADHD medication, with a contract value of $5,330.74. The order was competitively awarded without set-aside designation and carries a firm fixed price structure with an ultimate completion date of November 26, 2025. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a $2,010.28 delivery order to AmerisourceBergen Drug Corp for 90 capsules of Lisdexamfetamine 60 mg, a controlled pharmaceutical product used to treat attention-deficit/hyperactivity disorder. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 28, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation. This delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,070.16 for 100 capsules of Lisdexamfetamine 40 mg, a Schedule II controlled substance commonly prescribed for attention deficit hyperactivity disorder. This firm fixed-price delivery order, awarded on October 29, 2025, with an ultimate completion date of October 30, 2025, was competitively awarded with no set-aside designation. The order will be fulfilled from AmerisourceBergen's location in...
- The Defense Logistics Agency awarded a $2,051.06 firm fixed price delivery order to AmerisourceBergen Drug Corp for 100 capsules of Lisdexamfetamine 30 mg, a Schedule II controlled substance commonly used to treat attention deficit hyperactivity disorder. The order was competitively awarded without a set-aside designation and is scheduled for completion by September 16, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency (DLA) awarded a $2,834.93 delivery order to AmerisourceBergen Drug Corp for 90 capsules of Lisdexamfetamine 60 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder (ADHD). This competitively awarded, firm fixed-price contract was issued on October 21, 2025, with an ultimate completion date of October 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for 100 capsules of Lisdexamfetamine 40 mg, a controlled stimulant medication commonly prescribed for attention deficit hyperactivity disorder. This firm fixed-price delivery order, valued at approximately $2.98K, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99B prime vendor agreement running...
- The Defense Logistics Agency awarded a delivery order valued at $1,240.57 to AmerisourceBergen Drug Corp for 100 capsules of Lisdexamfetamine 40 mg, a Schedule II controlled substance commonly prescribed for attention-deficit/hyperactivity disorder. The contract was competitively awarded on June 25, 2025, with an ultimate completion date of June 26, 2025, and is classified as a firm fixed-price delivery order with no set-aside designation. Performance will occur at AmerisourceBergen's...